The Jarisch-Herxheimer reaction and fetal monitoring changes in pregnant women treated for syphilis.
OBJECTIVE
To estimate the incidence of the Jarisch-Herxheimer reaction in pregnant women undergoing treatment of syphilis and the incidence of changes in uterine activity or fetal heart rate (FHR).


METHODS
Pregnant women of at least 24 weeks' gestation diagnosed as needing treatment of syphilis were reviewed retrospectively. Patients were admitted for their first dose of benzathine penicillin, and the FHR was recorded continuously before and for 24 hours after injection. The occurrence of the Jarisch-Herxheimer reaction was noted, and all available FHR records for this admission were reviewed. Evaluations for changes in the FHR pattern and uterine activity were made. Statistical comparisons used Student t, Fischer exact, and chi2 tests, when applicable (significance P < .05).


RESULTS
We reviewed 50 charts and 31 available FHR records. The average gestational age was 30.8 weeks. We found 20 cases of probable Jarisch-Herxheimer reaction (40%). Thirteen of 31 patients (41.9%) developed regular uterine contractions, median onset, 10 hours. All resolved within 24 hours of treatment. Patients with uterine contractions had a greater mean increase in temperature (1.15F versus 0.68F, P < .008). Twelve of 31 women (38.7%) developed recurrent variable decelerations, median onset, 8 hours. All patients but one had their contractions resolve within 24 hours of treatment. Lower gestational age was associated with the occurrence of recurrent variable decelerations (29.6 weeks versus 32.3 weeks, P < .05). No patients required delivery at the time of treatment.


CONCLUSIONS
The incidence of Jarisch-Herxheimer reaction in treated syphilitic pregnancies is about 40%; similar proportions of patients develop regular uterine contractions and recurrent variable decelerations.
Myles
T D
TD
Department of Obstetrics and Gynecology, University of Illinois at Chicago, 60612, USA. tmyles@uic.edu
Elam
G
G
Park-Hwang
E
E
Nguyen
T
T
D000328:Adult; D005260:Female; D005323:Fetal Monitoring; D005334:Fever / Q000209:etiology*; D006340:Heart Rate, Fetal / Q000502:physiology*; D006801:Humans; D010401:Penicillin G Benzathine / Q000627:therapeutic use; D010406:Penicillins / Q000627:therapeutic use; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy* / Q000503:physiopathology; D012189:Retrospective Studies; D013223:Statistics as Topic; D013587:Syphilis / Q000188:drug therapy* / Q000503:physiopathology; D014590:Uterine Contraction / Q000502:physiology*
D010406:Penicillins; D010401:Penicillin G Benzathine